Sunscreen is safe and effective — if you choose correctly
(NewsNation) — A recent study showed that only 22 percent of sunscreen brands protect against UV radiation, but that doesn't mean you should ditch sunscreen altogether.
The anti-sunscreen movement, primarily housed on TikTok and social media, has labeled the summer staple as toxic for users. Last year, social media personalities spread misinformation that sunscreen causes cancer rather than prevents it.
However, experts maintain that sunscreen is a crucial part of preventing skin cancer, provided you apply the right type. Here's what to know.
Sunscreen is not inherently dangerous, but certain ingredients and chemicals could have adverse effects.
For example, ingredients oxybenzone and octinoxate are commonly used in chemical sunscreens but lack GRASE — 'generally recognized as safe and effective' — classification from the Food and Drug Administration.
The ingredients work to absorb and break down the sun's rays rather than shield or reflect them. The FDA recommends avoiding sunscreen that contains more than 5% of the ingredients, though there is no official warning against either.
While some chemicals may be questionable, foregoing your SPF could result in skin cancer — the most common kind in the United States. The American Academy of Dermatology estimates around 20% of the population will be diagnosed with the disease in their lifetime.
But what about that claim that sunscreen causes cancer? According to dermatologist Anisha Patel, M.D., there's no evidence for that correlation.
Instead, Patel said sunscreen protects your skin from harmful UV rays — if chosen carefully.
What SPF you slather on is all up to preference, though chemical and mineral sunscreens can offer different kinds of protection.
Known for its thicker texture and potential white cast, mineral sunscreens help reflect the sun from your skin and act as a shield, according to the Cleveland Clinic.
Compared to chemical formulas — which absorb sunlight and could contain those aforementioned ingredients — mineral sunscreen is easier on sensitive skin and provides immediate protection.
But mineral sunscreen isn't as effective at water-wicking as chemical compositions and may come off after some time in the pool or ocean.
Interested in mineral sunscreen? Keep an eye out for zinc oxide and titanium dioxide on the ingredients list. The pair is the only active sunscreen filter with GRASE status.
Whether you go chemical or mineral, dermatologists typically recommend finding a formula that provides both UVA and UVB radiation with an SPF of 30 or higher.
Other things to keep in mind:
You can also avoid sun exposure by wearing:
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
35 minutes ago
- Yahoo
Rescuers Respond to Call About a Neglected Dog. They Find a 'Leopard' Left with a Litter of Puppies
An animal shelter in Arizona was in for a surprise when they received a call about a "leopard" and some puppies in need of assistance The Arizona Humane Society rescued a pit bull terrier named Rainbow Brite — found painted to look like a leopard — and her nine puppies from 99-degree weather The 5-year-old dog and her puppies have received veterinary care and are in a foster home togetherAn animal shelter in Arizona was in for a surprise when they received a call about a "leopard" and some puppies in need of assistance. On Thursday, May 29, the Arizona Humane Society (AHS) in Phoenix received a call from a neighbor reporting a dog in need of help, as she and her nine puppies were tethered to a leash outdoors in the scorching Arizona heat. "The temperature that day in Phoenix was 99 degrees," a representative from AHS tells PEOPLE, and a photo of the rescue shows that the concrete sidewalk was even hotter, clocking in at 133 degrees. When the shelter's Emergency Animal Medical Technicians (EAMT) arrived on scene alongside officers from the Phoenix Police Department, they were in for quite the surprise — the mama dog, later named Rainbow Brite, was painted with multi-colored spots, meant to make her look like a leopard. "We don't know how or when she received her spots, but the condition she was in when our EAMTs arrived on scene indicated she was in need of help," AHS representative Joe Casados told Newsweek of the dogs' conditions. According to the representative, Rainbow Brite's owner surrendered the 5-year-old American pit bull terrier and her puppies to the shelter, agreeing that they "could no longer care for them." Rainbow Brite and her large litter went from their old home to the Lazin Animal Foundation Trauma Hospital, which is one of the largest level-one trauma pet hospitals in the U.S. According to AHS, Rainbow Brite's temperature was dangerously high, and veterinarians used cool towels to bring it down from 105.7 to 102.5. Vets also found that the mama dog was underweight—a concerning finding in a nursing dog, as she needs "calories to help keep her, and her puppies, healthy," the shelter tells PEOPLE. Eventually, AHS's staff stabilized Rainbow Brite. She and her nine pups — affectionately called her "sprites" — were transferred to AHS's "Mutternity Suites," a calming space dedicated to the shelter's pregnant and nursing mama dogs. Rainbow Brite's spots also made her a minor social media star. In a TikTok shared to the shelter's official account, a shelter representative visits the pit bull terrier in her enclosure and tells the viewers, "I heard we have a leopard in our mutternity suites." The video has over 75,000 views and shows Rainbow Brite happily nursing her litter and chowing down on some treats. "We don't know how or when she received her spots, but we are thankful she is cool, comfortable, and safe and getting the care she needs," the shelter tells PEOPLE. Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. According to AHS, the animal family of 10 will soon be available for adoption. However, for now, all the canines have been placed with a foster family. "When ready, they will return to the shelter for spay/neuter surgeries and vaccines before AHS will work to find everyone a new, safe home," AHS says, adding that the shelter has dozens of other pets in need of fostering. In a follow-up TikTok video, the shelter heavily advocated against leaving dogs outdoors in extreme heat. It noted that tethering a dog outside in several Arizona cities is illegal. "We are happy that her owner agreed to surrender her, so that Rainbow Brite and her nine sprites have a second chance at a new life," AHS said in the video. "Sharing her story is a reminder for everyone that she is just one of the many pets in the valley who are tied outside in our extreme weather." "The [AHS] strongly urges pet owners not to tether their pets, as it is extremely dangerous," the shelter added. "Rainbow did have her spots before we picked her up, and eventually the dye will fade. But for now, she will keep people guessing if she really is part leopard." Read the original article on People
Yahoo
an hour ago
- Yahoo
Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH
LungFit PH II's smaller, lightweight, transport-ready design is expected to open the entirety of the NO market Final design based upon substantial feedback from respiratory therapists across the countryGARDEN CITY, N.Y., June 16, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ('Beyond Air' or the 'Company'), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today announced the submission of a premarket approval (PMA) supplement application to the U.S. Food and Drug Administration (FDA) for LungFit PH II, the next-generation therapeutic nitric oxide generator. Beyond Air has developed its LungFit PH II system to be smaller, lighter and fully transport-ready — while delivering all the breakthrough features of the currently FDA-approved version from the Company's therapeutic platform of nitric oxide generators targeting pulmonary disease. The new system uses the same Smart Filter and accessories as the first-generation device, ensuring continuity, streamlined logistics, and minimal disruption for existing customers. The LungFit PH platform uses the Company's patented Ionizer™ technology to generate unlimited on-demand nitric oxide from ambient air, which is then able to be delivered directly to a ventilator circuit, regardless of dose or flow. The LungFit PH system uses the equivalent power of a 60-watt lightbulb to ionize the nitrogen and oxygen molecules, forming nitric oxide with low levels of nitrogen dioxide (NO2) created as a byproduct. The gas then passes through a Smart Filter, which removes the toxic NO2 from the internal circuit. For the treatment of PPHN, the novel LungFit PH system is designed to deliver NO doses consistent with the current standard of care for delivery of 20 ppm NO, with a range of 0.5 ppm – 80 ppm (low concentration NO), for ventilated patients. Each Smart Filter provides 12 hours of therapy regardless of ventilator demands and can be replaced in seconds for uninterrupted treatment. 'We are pleased to announce that development of our transport-ready LungFit PH II has resulted in a NO system which we believe is far superior to legacy systems currently available in the market. While our first-generation system already delivers key advantages to hospitals, this next-generation device raises the bar with a reduced weight and footprint, simplified operation, longer service interval, and full compatibility with both air and ground transport. It also includes an automated backup system that retains most primary system capabilities,' said Steve Lisi, Chairman and Chief Executive Officer of Beyond Air. 'Once approved, we are confident that the introduction of LungFit PH II will play a pivotal role in accelerating our market expansion and advancing our position as a global leader in hospital-based NO delivery.' NO gas is a vasodilator approved in dozens of countries to improve oxygenation and reduce the need for extracorporeal membrane oxygenation (ECMO) in term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilator support and other appropriate agents. Low concentration inhaled NO therapy has been the standard-of-care for PPHN for over 20 years in the United States. PPHN is a lethal condition and secondary to failure of normal circulatory transition at birth. It is a syndrome characterized by elevated pulmonary vascular resistance (PVR) that causes labile hypoxemia due to decreased pulmonary blood flow and right-to-left shunting of blood. Its incidence has been reported as 1.9 per 1,000 live births (0.4-6.8/1,000 live births) with a mortality rate ranging between 4-33%. This syndrome complicates the course of about 10% of infants with respiratory failure and remains a source of considerable morbidity and mortality. In the European Union and many other countries outside the United States, NO is also approved for the treatment of peri- and post-operative pulmonary hypertension in adults and newborn infants, infants and toddlers, children and adolescents, ages 0-17 years in conjunction to heart surgery, in order to selectively decrease pulmonary arterial pressure and improve right ventricular function. About LungFit *Beyond Air's LungFit is a cylinder-free, phasic flow generator and delivery system designated as a medical device by the U.S. Food and Drug Administration (FDA). The ventilator-compatible version of the device can generate NO from ambient air on demand for delivery to the lungs at concentrations ranging from 1 ppm to 80 ppm. The LungFit system could potentially replace large, high-pressure NO cylinders, providing significant advantages in the hospital setting, including greatly reducing inventory and storage requirements, improving overall safety by eliminating NO2 purging steps, and offering other operational benefits. LungFit can also deliver NO at concentrations at or above 80 ppm for potentially treating severe acute lung infections in the hospital setting (e.g., COVID-19, bronchiolitis) and chronic, refractory lung infections in the home setting (e.g., NTM). With the elimination of cylinders, Beyond Air intends to offer NO treatment in the home setting. *Beyond Air's LungFit PH is approved for commercial use in the United States, European Union, Australia, Thailand and New Zealand. Beyond Air's other LungFit systems are not approved for commercial use and are for investigational use only. Beyond Air is not suggesting NO use over 80 ppm or use at home. About PPHNPersistent pulmonary hypertension of the newborn (PPHN) is a lethal condition and secondary to failure of normal circulatory transition at birth. It is a syndrome characterized by elevated pulmonary vascular resistance (PVR) that causes labile hypoxemia due to decreased pulmonary blood flow and right-to-left shunting of blood. Its incidence has been reported as 1.9 per 1,000 live births (0.4–6.8/1000 live births) with mortality rate ranging between 4–33%. This syndrome complicates the course of about 10% of infants with respiratory failure and remains a source of considerable morbidity and mortality. NO gas is a vasodilator, is approved in dozens of countries to improve oxygenation and reduces the need for extracorporeal membrane oxygenation (ECMO) in term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilator support and other appropriate agents. About Beyond Air®, Air is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received FDA approval and CE Mark for its first system, LungFit® PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. Beyond Air is currently advancing its other revolutionary LungFit systems in clinical trials for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19) and nontuberculous mycobacteria (NTM). The Company has also partnered with The Hebrew University of Jerusalem to advance a pre-clinical program dedicated to the treatment of autism spectrum disorder (ASD) and other neurological disorders. Additionally, Beyond Cancer, Ltd., an affiliate of Beyond Air, is investigating ultra-high concentrations of NO with a proprietary delivery system to target certain solid tumors in the pre-clinical setting. For more information, visit Forward Looking StatementsThis press release contains 'forward-looking statements' concerning the potential safety and efficacy of inhaled nitric oxide and the ultra-high concentration nitric oxide product candidate, as well as its therapeutic potential in a number of indications; and the potential impact on patients and anticipated benefits associated with inhaled nitric oxide and the ultra-high concentration nitric oxide product candidate. Forward-looking statements include statements about expectations, beliefs, or intentions regarding product offerings, business, results of operations, strategies or prospects. You can identify such forward-looking statements by the words 'appears,' 'expects,' 'plans,' 'anticipates,' 'believes' 'expects,' 'intends,' 'looks,' 'projects,' 'goal,' 'assumes,' 'targets' and similar expressions and/or the use of future tense or conditional constructions (such as 'will,' 'may,' 'could,' 'should' and the like) and by the fact that these statements do not relate strictly to historical or current matters. Rather, forward-looking statements relate to anticipated or expected events, activities, trends or results as of the date they are made. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause actual results to differ materially from any future results expressed or implied by the forward-looking statements. These forward-looking statements are only predictions and reflect views as of the date they are made with respect to future events and financial performance. Many factors could cause actual activities or results to differ materially from the activities and results anticipated in forward-looking statements, including risks related to the ability to raise additional capital; the timing and results of future pre-clinical studies and clinical trials; the potential that regulatory authorities, including the FDA and comparable non-U.S. regulatory authorities, may not grant or may delay approval for our product candidates; the approach to discover and develop novel drugs, which is unproven and may never lead to efficacious or marketable products; the ability to fund and the results of further pre-clinical studies and clinical trials of our product candidates; obtaining, maintaining and protecting intellectual property utilized by products; obtaining regulatory approval for products; competition from others using similar technology and others developing products for similar uses; dependence on collaborators; and other risks, which may, in part, be identified and described in the 'Risk Factors' section of Beyond Air's most recent Annual Report on Form 10-K and other of its filings with the Securities and Exchange Commission, all of which are available on Beyond Air's website. Beyond Air and Beyond Cancer undertake no obligation to update, and have no policy of updating or revising, these forward-looking statements, except as required by applicable law. CONTACTS:Investor Relations contactsCorey Davis, Advisors, LLCCdavis@ 915-2577 A photo accompanying this announcement is available at
New York Post
an hour ago
- New York Post
Avoid this ‘fancy' seasoning to protect yourself from heart disease and stroke: cardiologist
It's time to spice things down. Seasoning is arguably the most exciting part of eating food, as it has the power to enhance natural flavors and add complexity to any dish. But one cardiologist is sounding the alarm on a supposedly upscale seasoning — and, fair warning, her advice might leave you feeling salty. Advertisement 3 Seasoning is arguably the most exciting part of eating food, as it has the power to enhance natural flavors and add complexity to any dish. Tobias – While salt is an essential electrolyte that plays a crucial role in fluid balance and nerve and muscle function, too much of it can spike your blood pressure, thereby increasing your risk of heart disease and stroke. The American Heart Association advises limiting sodium intake to no more than 2,300 milligrams per day — roughly one teaspoon of table salt — with an ideal target of 1,500 mg for most adults, especially those with high blood pressure. Advertisement However, the average American consumes around 3,400 mg of sodium daily. And not all salt is created equal, either. While coarse salt has been deemed the most sophisticated choice of sodium chloride, mostly thanks to its popularity among professional chefs — and the cute little ramekins they use to store it in — it might not be the healthiest option. Dr. Susan Cheng, a cardiologist in the Smidt Heart Institute at Cedars-Sinai in Los Angeles, told that the crunchy texture of this 'fancy' salt might make it easier to overindulge. Advertisement 3 Too much salt can spike your blood pressure, thereby increasing your risk of heart disease and stroke. LIGHTFIELD STUDIOS – 'The less expensive regular salt you get from the grocery store that is not so fancy or coarse gives you as much taste for much less volume of salt. You're ingesting less salt,' Cheng told the outlet. Cardiologist Dr. Evan Levine has also previously warned his nearly 225,000 TikTok followers against jumping on the trendy salt train. Advertisement In a video on the biggest TikTok healthcare lies, he ranted against the Celtic sea salt craze, which has gained traction because it's less processed and contains negligible amounts of minerals. 'Guess what? It's sodium chloride like your salt,' he said. 'It has trace — little itsy bitsy — amounts of calcium, potassium … and that's it.' 3 'The less expensive regular salt you get from the grocery store that is not so fancy or coarse gives you as much taste for much less volume of salt. You're ingesting less salt,' Cheng said. beats_ – Experts generally agree that regular table salt is actually the healthiest choice for most people. That's because it's fortified with iodine, an essential mineral that helps prevent iodine deficiency, which can lead to thyroid problem. Many gourmet salts — such as Himalayan, Kosher or sea salt — don't contain added iodine. Advertisement Table salt has smaller, uniform grains, so you're more likely to use less without sacrificing flavor. And it's regulated for purity and consistency, which means fewer contaminants or trace heavy metals that can sometimes show up in unrefined salts.
